InvestLog
UNCY Unicycive Therapeutics, Inc. logo

UNCY Unicycive Therapeutics, Inc.

Healthcare
$7.06-12.62%ClosedMarket Cap: $151.7M

As of 2026-05-26

Insider Statistics (Q3 2025)

Acquisitions

8

Dispositions

1

Buy/Sell Ratio

8.00

Net Shares

+1,148,301

Shares Acquired

1,151,500

Shares Disposed

3,199

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu May 21Kenkare-Mitra SaradirectorSell84,200$0.0084,200
Thu May 21Kenkare-Mitra SaradirectorSell42,100$0.00126,300
Thu May 21Gupta Shalabh K.director, officer: CEOSell762,200$0.00762,200
Wed May 20Townsend Johnofficer: CFOSell169,500$0.00169,500
Wed May 20Jermasek Douglasofficer: EVP, Corporate StrategySell169,500$0.00169,500
Wed May 20Gupta Pramodofficer: EVP, Pharmaceuticals and BDSell169,500$0.00169,500
Mon May 18Laumas SandeepdirectorSell84,200$0.0084,200
Mon May 18Laumas SandeepdirectorSell42,100$0.00126,300
Tue Aug 26Aggarwal GauravdirectorSell3,199$4.900
Tue Aug 26Aggarwal GauravdirectorSell652,900$0.001,789,915
Wed Jul 30Townsend Johnofficer: Chief Financial OfficerSell10,000$4.71101,557
Wed Jul 30Laumas SandeepdirectorSell21,200$4.7141,286
Wed Jul 30Kenkare-Mitra SaradirectorSell21,200$4.7139,200
Wed Jul 30Jermasek Douglasofficer: EVP of Corporate StrategySell10,000$4.71215,500
Wed Jul 30Gupta Shalabh K.director, officer: CEOSell325,000$4.71968,951